Menemedengue V., Sahnouni K., Basco Leonardo, Tahar Rachida. (2011). Molecular epidemiology of malaria in Cameroon. XXX. Sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyrimethamine combination. American Journal of Tropical Medicine and Hygiene, 85 (1), p. 22-25. ISSN 0002-9637.
Titre du document
Molecular epidemiology of malaria in Cameroon. XXX. Sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyrimethamine combination
Menemedengue V., Sahnouni K., Basco Leonardo, Tahar Rachida
Source
American Journal of Tropical Medicine and Hygiene, 2011,
85 (1), p. 22-25 ISSN 0002-9637
Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes are reliable molecular markers for antifolate resistance. The P. falciparum ATPase 6 (pfatp6) gene has been proposed to be a potential marker for artemisinin resistance. In our previous clinical study, we showed that artesunate-sulfadoxine-pyrimethamine is highly effective against uncomplicated malaria in Yaounde, Cameroon. In the present study, dhfr, dhps, and pfatp6 mutations in P falciparum isolates obtained from children treated with artesunate-sulfadoxine-pyrimethamine were determined. All 61 isolates had wild-type Pfatp6 263, 623, and 769 alleles, and 11(18%) had a single E431K substitution. Three additional mutations, E643Q, E432K, and E641Q, were detected. The results did not indicate any warning signal of serious concern (i.e., no parasites were seen with quintuple dhfr-dhps, DHFR Ile164Leu, or pfatp6 mutations), as confirmed by the high clinical efficacy of artesunate-sulfadoxine-pyrimethamine. Further studies are required to identify a molecular marker that reliably predicts artemisinin resistance.
